Orchid Pharma rises 4% on deal with Cipla to roll out new UTI drug in India
1 day ago•Business Standard
Orchid Pharma partners with Cipla for pan-India distribution of Cefepime-Enmetazobactam
3 days ago•Business Standard
Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
4 days ago•Business Standard
Orchid Pharma join hands with Cipla to launch new antibiotic in India
4 days ago•Business Standard
Market Opening LIVE | Nifty Opens Below 23,400, Sensex Down 440 Points; Cipla, JSW Energy In Focus
1 week ago•CNBC-TV18
Stocks To Watch: TVS Motors, IREDA, SAIL, Religare, Adani Ports, Cipla, And Others - News18
1 week ago•News18
Stocks to watch on June 24: Sun Pharma, Cipla, Lupin, Vedanta, Tata Steel
1 week ago•Business Standard
Cipla Goa facility gets 6 USFDA observations
1 week ago•Business Standard
Takeda Gives Sun Pharma, Cipla Rights to Commercialise Gastro Drug in India - News18
1 week ago•News18
Cipla invests additional 3 mn euro in mRNA technology company Ethris
2 weeks ago•Business Standard